WHAT THIS STUDY ADDS
Current evidence does not indicate that neuraminidase inhibitor exposure during pregnancy is not associated with increased risks of overall congenital malformations in offspring.
Furthermore analysis did not indicate increased risks of other adverse neonatal outcomes in offspring exposed to neuraminidase inhibitors.
This study supports the current guidelines stating that oseltamivir is recommended for influenza treatment during pregnancy.